Pentraxin-3 levels were significantly higher in UC patients compared to patients with active CC or LC in addition to all the other groups, although active CC patients had significantly increased levels compared to diarrhea controls (Figure 4G). The gene discussed is PTX3; the disease is laryngotracheoesophageal cleft.